Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ – Get Free Report) was the target of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 40,400 shares, a growth of 124.4% from the January 15th total of 18,000 shares. Currently, 2.4% of the shares of the company are sold short. Based on an average trading volume of 47,100 shares, the days-to-cover ratio is presently 0.9 days.
Creative Medical Technology Price Performance
Shares of CELZ stock opened at $4.74 on Friday. The company’s fifty day simple moving average is $2.66 and its two-hundred day simple moving average is $3.07. Creative Medical Technology has a 1 year low of $1.96 and a 1 year high of $10.28. The stock has a market capitalization of $8.29 million, a price-to-earnings ratio of -1.25 and a beta of 1.85.
Institutional Investors Weigh In On Creative Medical Technology
A hedge fund recently bought a new stake in Creative Medical Technology stock. Geode Capital Management LLC bought a new stake in shares of Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 10,308 shares of the company’s stock, valued at approximately $25,000. Geode Capital Management LLC owned 0.59% of Creative Medical Technology at the end of the most recent reporting period. 1.42% of the stock is owned by institutional investors and hedge funds.
About Creative Medical Technology
Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.
Featured Stories
- Five stocks we like better than Creative Medical Technology
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Dividend Capture Strategy: What You Need to Know
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- How to invest in marijuana stocks in 7 steps
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Creative Medical Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creative Medical Technology and related companies with MarketBeat.com's FREE daily email newsletter.
